Tyler G. Ketterl

Tyler G. Ketterl

Auto-generated profile, based on publicly available information

Tyler G. Ketterl

Ben Towne Center For Childhood Cancer and Blood Disorders Research Seattle Children's Hospital Seattle Washington USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Cancer
Verified
Journal Article
Open access
PDF file
TKTyler G. Ketterl
Tyler G. Ketterl
KSKaren L. Syrjala
Karen L. Syrjala
JCJacqueline Casillas
Jacqueline Casillas
LJLinda A. Jacobs
Linda A. Jacobs
SPSteven C. Palmer
Steven C. Palmer
KBKevin Scott Baker
Kevin Scott Baker
Background: The impact of cancer and its treatment on employment and financial burden in adolescents/young adults (AYAs) is not fully known. Methods: Eligibility for this cross‐sectional study of AYA cancer survivors included the diagnosis of a malignancy between ages 18 and 39 years and survey completion within 1 to 5 years from diagnosis and ≥1 year after therapy completion. Participants were selected randomly from the tumor registries of 7 participating sites and completed an online patient‐reported outcomes survey to assess employment and financial concerns. Treatment data were abstracted from medical records. Data were analyzed across diagnoses and by tumor site using logistic regression and Wald‐based 95% confidence intervals adjusting for age (categorized), sex, insurance status, education (categorized), and treatment exposures. Results: Participants included 872 survivors (breast cancer, n = 241; thyroid cancer, n = 126; leukemia/lymphoma, n = 163; other malignancies, n = 342). Exposure to chemotherapy in breast cancer survivors was associated with an increase in self‐reported mental impairment in work tasks (odds ratio [OR], 2.66) and taking unpaid time off (OR, 2.62); survivors of “other” malignancies reported an increase in mental impairment of work tasks (OR, 3.67) and borrowing >$10,000 (OR, 3.43). Radiation exposure was associated with an increase of mental impairment in work tasks (OR, 2.05) in breast cancer survivors, taking extended paid time off work in thyroid cancer survivors (OR, 5.05), and physical impairment in work tasks in survivors of “other” malignancies (OR, 3.11). Finally, in survivors of “other” malignancies, having undergone surgery was associated with an increase in physical (OR, 3.11) and mental impairment (OR, 2.31) of work tasks. Conclusions: Cancer treatment has a significant impact on AYA survivors’ physical and mental work capacity and time off from work.

6 March 2018 in Maternal and Child Health Journal
Verified
Journal Article
Closed access
PDF file
TKTyler G. Ketterl
Tyler G. Ketterl
NDNicolas J. Dundas
Nicolas J. Dundas
SRSteven A. Roncaioli
Steven A. Roncaioli
ALAlyson J. Littman
Alyson J. Littman
APAmanda I. Phipps
Amanda I. Phipps

1 March 2018 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
TKTyler G. Ketterl
Tyler G. Ketterl
ECEric J. Chow
Eric J. Chow
WLWendy M. Leisenring
Wendy M. Leisenring
PGPam Goodman
Pam Goodman
IKIldi H. Koves
Ildi H. Koves
KBK. Scott Baker
K. Scott Baker
Adult survivors of acute leukemia in childhood have a higher-than-expected frequency of obesity and are at increased risk for metabolic syndrome and early mortality from cardiovascular disease (CVD). Adipose tissue has been recognized as an endocrine and paracrine organ that secretes various adipokines involved in metabolic regulation and inflammatory processes. In this study, we examined inflammatory factors (IL-6 and TNF-α) and adipokines (adiponectin, leptin), in addition to body composition and adiposity, in cancer survivors who underwent hematopoietic cell transplantation (HCT) during childhood compared with sibling controls. Over 2-year survivors of HCT for hematologic malignancies during childhood were recruited from 2 institutions along with a control population of siblings. Participants underwent evaluation for body composition, anthropometric measurements, and assessment of CVD risk factors and adipokines. Cases were stratified by radiation exposure in the preparative regimen (total body irradiation [TBI] + central nervous system [CNS] irradiation, TBI only, chemotherapy only) and adjusted least squares means were estimated for each adipokine and adjusted by age, sex, race, Tanner stage, and percent fat mass (PFM) percentiles (0-24, 25-74, 75+). A total of 151 HCT survivors and 92 siblings underwent evaluation. Significant differences in mean adipokine levels were detected between survivors and siblings; leptin was significantly higher and adiponectin significantly lower in HCT survivors who received TBI with or without CNS irradiation compared with siblings. IL-6 was significantly higher in all groups of HCT survivors compared with siblings. Body mass index (BMI) was similar in survivors and controls, although PFM was significantly higher in all groups of HCT survivors and lean body mass (LBM) was lower in survivors who received TBI with or without CNS radiation compared with siblings. HCT survivors showed an unfavorable profile of inflammation, adipokines, and adiposity, despite similar BMI as controls. Higher PFM and lower LBM may contribute to these findings. TBI exposure is correlated with greater severity of these observations. Increasing LBM may represent a tangible target for mitigating the high cardiometabolic risks of HCT survivors.

2 March 2016 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PDF file
ELEveline J. Langereis
Eveline J. Langereis
MOMatthijs M. Den Os
Matthijs M. Den Os
CBCatherine Breen
Catherine Breen
SJSimon Jones
Simon Jones
OKOlga C. Knaven
Olga C. Knaven
FWFrits Wijburg
Frits Wijburg
Dysostosis multiplex contributes substantially to morbidity in patients with Hurler syndrome (mucopolysaccharidosis type I Hurler phenotype [MPS I-H]), even after successful hematopoietic stem cell transplantation (HSCT). One of the hallmarks of dysostosis multiplex in MPS I-H is hip dysplasia, which often requires surgical intervention. We sought to describe in detail the course of hip dysplasia in this group of patients, as assessed by radiographic analysis, and to identify potential outcome predictors. Longitudinal data were obtained from digitally scored pelvic radiographs of patients with MPS I-H using OrthoGon software for parameters including, but not limited to, the acetabular index, migration percentage, Smith ratio, and neck-shaft angle. Scoring was performed independently by two blinded observers. Additional information on genotype, enzyme replacement therapy pre-HSCT, donor chimerism, and enzyme activity post-HSCT were obtained. General trends and potential correlations were calculated with mixed-model statistics. Fifty-two patients (192 radiographs) were included in this analysis. Intraobserver and interobserver variation analysis showed an intraclass correlation coefficient ranging from 0.78 to 1.00. Among the twenty-one patients with follow-up beyond the age of five years, the acetabular index was in the range of severe hip dysplasia in up to 86% of the patients. Severe coxa valga was seen in 91% of the patients. Lateral and superior femoral displacement were highly prevalent, with the migration percentage outside the reference range in up to 96% of the patients. Finally, anterior pelvic tilt increased with age (p = 0.001). No correlations were identified between clinical parameters and radiographic findings. Our study shows that progressive acetabular dysplasia as well as coxa valga and hip displacement are highly prevalent and progressive over time in patients with MPS I-H, despite successful HSCT. These data may provide essential natural history determinations for the assessment of efficacy of new therapeutic strategies aimed at improving skeletal outcomes in patients with MPS I-H. Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

19 May 2021 in JCO Oncology Practice
Verified
Journal Article
Closed access
TKTyler G. Ketterl
Tyler G. Ketterl

5 January 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
MMMeghan E. McGrady
Meghan E. McGrady
TKTyler G. Ketterl
Tyler G. Ketterl
RNRobin E. Norris
Robin E. Norris
JPJohn P. Perentesis
John P. Perentesis
DPDaniel Pettee
Daniel Pettee
APAhna L. H. Pai
Ahna L. H. Pai